• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

是否应该对公共资金用于辅助生殖技术设定女性年龄限制?

Should there be a female age limit on public funding for assisted reproductive technology?

机构信息

School of Population Health, The University of Adelaide, Adelaide, Australia 5005.

出版信息

J Bioeth Inq. 2013 Mar;10(1):79-91. doi: 10.1007/s11673-012-9415-6. Epub 2013 Jan 4.

DOI:10.1007/s11673-012-9415-6
PMID:23288441
Abstract

Should there be a female age limit on public funding for assisted reproductive technology (ART)? The question bears significant economic and sociopolitical implications and has been contentious in many countries. We conceptualise the question as one of justice in resource allocation, using three much-debated substantive principles of justice-the capacity to benefit, personal responsibility, and need-to structure and then explore a complex of arguments. Capacity-to-benefit arguments are not decisive: There are no clear cost-effectiveness grounds to restrict funding to those older women who still bear some capacity to benefit from ART. Personal responsibility arguments are challenged by structural determinants of delayed motherhood. Nor are need arguments decisive: They can speak either for or against a female age limit, depending on the conception of need used. We demonstrate how these principles can differ not only in content but also in the relative importance they are accorded by governments. Wide variation in ART public funding policy might be better understood in this light. We conclude with some inter-country comparison. New Zealand and Swedish policies are uncommonly transparent and thus demonstrate particularly well how the arguments we explore have been put into practice.

摘要

是否应对公共资金用于辅助生殖技术 (ART) 的女性年龄设限?这个问题具有重大的经济和社会政治影响,在许多国家都存在争议。我们将这个问题视为资源分配公正的问题,使用三个备受争议的公正实质性原则——受益能力、个人责任和需求——来构建和探讨一系列论点。受益能力论点不具有决定性:没有明确的成本效益依据将资金限制在那些仍然有一定能力从 ART 中受益的年长女性身上。个人责任论点受到晚育的结构性决定因素的挑战。需求论点也不具有决定性:它们可以支持或反对对女性年龄设限,具体取决于所使用的需求概念。我们展示了这些原则不仅在内容上而且在政府赋予它们的相对重要性上都可能存在差异。从这一角度出发,我们可以更好地理解辅助生殖技术公共资金政策的广泛差异。最后我们进行了一些国家间的比较。新西兰和瑞典的政策异常透明,因此特别清楚地展示了我们所探讨的论点是如何付诸实践的。

相似文献

1
Should there be a female age limit on public funding for assisted reproductive technology?是否应该对公共资金用于辅助生殖技术设定女性年龄限制?
J Bioeth Inq. 2013 Mar;10(1):79-91. doi: 10.1007/s11673-012-9415-6. Epub 2013 Jan 4.
2
A comparative analysis of assisted reproductive technology cycles in Australia and New Zealand 2004-2007.澳大利亚和新西兰 2004-2007 年辅助生殖技术周期的比较分析。
Hum Reprod. 2010 Sep;25(9):2281-9. doi: 10.1093/humrep/deq187. Epub 2010 Jul 22.
3
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups.撤资政策与辅助生殖技术的公共资金:与三个关键利益相关者群体进行审议性参与的结果
BMC Health Serv Res. 2014 May 5;14:204. doi: 10.1186/1472-6963-14-204.
4
Assisted reproductive technology treatment costs of a live birth: an age-stratified cost-outcome study of treatment in Australia.活产的辅助生殖技术治疗成本:澳大利亚治疗的年龄分层成本-结果研究
Med J Aust. 2006 Feb 20;184(4):155-8. doi: 10.5694/j.1326-5377.2006.tb00174.x.
5
Access to assisted reproductive technologies in France: the emergence of the patients' voice.法国辅助生殖技术的获取情况:患者声音的浮现
Med Health Care Philos. 2013 Feb;16(1):55-68. doi: 10.1007/s11019-012-9402-z.
6
[Resource allocation and justice in distribution of services in medical management of elderly patients].[老年患者医疗管理中服务分配的资源配置与公平性]
Z Gerontol Geriatr. 2002 Aug;35(4):361-8. doi: 10.1007/s00391-002-0077-6.
7
Assisted reproductive technology: public funding and the voluntary shift to single embryo transfer in Australia.辅助生殖技术:澳大利亚公共资金与自愿向单胚胎移植的转变。
Med J Aust. 2011 Nov 21;195(10):594-8. doi: 10.5694/mja10.11448.
8
Socioeconomic disparities in access to ART treatment and the differential impact of a policy that increased consumer costs.社会经济差异对接受抗逆转录病毒治疗的影响,以及一项增加消费者成本的政策的不同影响。
Hum Reprod. 2013 Nov;28(11):3111-7. doi: 10.1093/humrep/det302. Epub 2013 Aug 1.
9
International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology 2012†.国际辅助生殖技术监测委员会世界报告:辅助生殖技术 2012 年报告†。
Hum Reprod. 2020 Aug 1;35(8):1900-1913. doi: 10.1093/humrep/deaa090.
10
What counts and how to count it: physicians' constructions of evidence in a disinvestment context.有哪些指标以及如何衡量它们:在不投资的背景下,医生对证据的构建。
Soc Sci Med. 2012 Dec;75(12):2191-9. doi: 10.1016/j.socscimed.2012.08.016. Epub 2012 Aug 27.

引用本文的文献

1
Sustainability in Health care by Allocating Resources Effectively (SHARE) 10: operationalising disinvestment in a conceptual framework for resource allocation.通过有效分配资源实现医疗保健可持续性(SHARE)10:在资源分配概念框架中实施撤资
BMC Health Serv Res. 2017 Sep 8;17(1):632. doi: 10.1186/s12913-017-2506-7.
2
Sustainability in Health care by Allocating Resources Effectively (SHARE) 9: conceptualising disinvestment in the local healthcare setting.通过有效分配资源实现医疗保健可持续性(SHARE)9:对当地医疗环境中的撤资进行概念化。
BMC Health Serv Res. 2017 Sep 8;17(1):633. doi: 10.1186/s12913-017-2507-6.
3
Sustainability in health care by allocating resources effectively (SHARE) 4: exploring opportunities and methods for consumer engagement in resource allocation in a local healthcare setting.

本文引用的文献

1
Development of clinical priority access criteria for assisted reproduction and its evaluation on 1386 infertile couples in New Zealand.制定新西兰辅助生殖临床优先准入标准及其对 1386 对不孕夫妇的评估
Hum Reprod. 2012 Jan;27(1):131-41. doi: 10.1093/humrep/der372. Epub 2011 Nov 10.
2
The appeal to nature implicit in certain restrictions on public funding for assisted reproductive technology.某些对辅助生殖技术公共资金限制中所隐含的诉诸自然。
Bioethics. 2011 Oct;25(8):463-71. doi: 10.1111/j.1467-8519.2011.01925.x.
3
Considering the risks to economically disadvantaged egg donors.
通过有效分配资源实现医疗保健的可持续性(SHARE)4:探索在当地医疗环境中让消费者参与资源分配的机会和方法。
BMC Health Serv Res. 2017 May 5;17(1):329. doi: 10.1186/s12913-017-2212-5.
4
The Best Age for Pregnancy and Undue Pressures.怀孕的最佳年龄与不当压力
J Family Reprod Health. 2016 Sep;10(3):104-107.
5
Depression and Anxiety Outcomes Associated with Failed Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis.与辅助生殖技术失败相关的抑郁和焦虑结局:一项系统评价和荟萃分析。
PLoS One. 2016 Nov 11;11(11):e0165805. doi: 10.1371/journal.pone.0165805. eCollection 2016.
6
Disinvestment policy and the public funding of assisted reproductive technologies: outcomes of deliberative engagements with three key stakeholder groups.撤资政策与辅助生殖技术的公共资金:与三个关键利益相关者群体进行审议性参与的结果
BMC Health Serv Res. 2014 May 5;14:204. doi: 10.1186/1472-6963-14-204.
考虑到经济上处于不利地位的卵子捐赠者所面临的风险。
Am J Bioeth. 2011 Sep;11(9):44-5. doi: 10.1080/15265161.2011.598385.
4
Assisted reproductive technologies: a systematic review of safety and effectiveness to inform disinvestment policy.辅助生殖技术:一项安全性和有效性的系统评价,为投资决策提供信息。
Health Policy. 2011 Oct;102(2-3):200-13. doi: 10.1016/j.healthpol.2011.07.007. Epub 2011 Aug 24.
5
The Life Journeys Of Young Women Project: objectives, design, and recruitment results.《年轻女性生活历程项目》:目标、设计和招募结果。
Am J Epidemiol. 2011 Jul 1;174(1):72-80. doi: 10.1093/aje/kwr047. Epub 2011 May 30.
6
Adverse outcomes from IVF.体外受精的不良后果。
BMJ. 2011 Jan 27;342:d436. doi: 10.1136/bmj.d436.
7
Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions.在医疗保健决策中使用每获得一个质量调整生命年的成本阈值。
Int J Technol Assess Health Care. 2011 Jan;27(1):71-6. doi: 10.1017/S0266462310001194. Epub 2011 Jan 25.
8
A comparative analysis of assisted reproductive technology cycles in Australia and New Zealand 2004-2007.澳大利亚和新西兰 2004-2007 年辅助生殖技术周期的比较分析。
Hum Reprod. 2010 Sep;25(9):2281-9. doi: 10.1093/humrep/deq187. Epub 2010 Jul 22.
9
Egg donation: issues & concerns.捐卵:问题与担忧。
MCN Am J Matern Child Nurs. 2010 May-Jun;35(3):132-7; quiz 137-9. doi: 10.1097/NMC.0b013e3181d763b9.
10
A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts.按母龄和尝试治疗次数划分的体外受精的成本效益分析。
Hum Reprod. 2010 Apr;25(4):924-31. doi: 10.1093/humrep/dep418. Epub 2010 Jan 26.